These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38438440)

  • 1. Impacts of optimal control strategies on the HBV and COVID-19 co-epidemic spreading dynamics.
    Teklu SW
    Sci Rep; 2024 Mar; 14(1):5328. PubMed ID: 38438440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifurcation and optimal control analysis of HIV/AIDS and COVID-19 co-infection model with numerical simulation.
    Kotola BS; Teklu SW; Abebaw YF
    PLoS One; 2023; 18(5):e0284759. PubMed ID: 37146033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of HBV and COVID-19 Coinfection Model with Intervention Strategies.
    Teklu SW
    Comput Math Methods Med; 2023; 2023():6908757. PubMed ID: 37811291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex dynamics and control analysis of an epidemic model with non-monotone incidence and saturated treatment.
    Saha P; Ghosh U
    Int J Dyn Control; 2023; 11(1):301-323. PubMed ID: 35637768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Analysis and Optimal Control Model of COVID-19.
    Nana-Kyere S; Boateng FA; Jonathan P; Donkor A; Hoggar GK; Titus BD; Kwarteng D; Adu IK
    Comput Math Methods Med; 2022; 2022():9491847. PubMed ID: 35126644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of COVID-19 with multiple variants of the virus under optimal control in Ghana.
    Kim YR; Min Y; Okogun-Odompley JN
    PLoS One; 2024; 19(7):e0303791. PubMed ID: 38954691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global investigation for an "SIS" model for COVID-19 epidemic with asymptomatic infection.
    Alharbi MH
    Math Biosci Eng; 2023 Jan; 20(3):5298-5315. PubMed ID: 36896546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical analysis of the transmission dynamics of COVID-19 infection in the presence of intervention strategies.
    Teklu SW
    J Biol Dyn; 2022 Dec; 16(1):640-664. PubMed ID: 35972455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematical modeling and optimal intervention strategies of the COVID-19 outbreak.
    Mondal J; Khajanchi S
    Nonlinear Dyn; 2022; 109(1):177-202. PubMed ID: 35125654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mathematical Model of COVID-19 with Vaccination and Treatment.
    Diagne ML; Rwezaura H; Tchoumi SY; Tchuenche JM
    Comput Math Methods Med; 2021; 2021():1250129. PubMed ID: 34497662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional epidemic model of coronavirus disease with vaccination and crowding effects.
    Saleem S; Rafiq M; Ahmed N; Arif MS; Raza A; Iqbal Z; Niazai S; Khan I
    Sci Rep; 2024 Apr; 14(1):8157. PubMed ID: 38589475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational analysis of control of hepatitis B virus disease through vaccination and treatment strategies.
    Butt AIK; Imran M; Aslam J; Batool S; Batool S
    PLoS One; 2023; 18(10):e0288024. PubMed ID: 37883381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-dynamics of COVID-19 and TB with COVID-19 vaccination and exogenous reinfection for TB: An optimal control application.
    Kifle ZS; Obsu LL
    Infect Dis Model; 2023 Jun; 8(2):574-602. PubMed ID: 37287990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic modeling and analysis of Hepatitis B epidemic with general incidence.
    Xue T; Zhang L; Fan X
    Math Biosci Eng; 2023 Apr; 20(6):10883-10908. PubMed ID: 37322965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the dynamics of COVID-19 in the presence of Delta and Omicron variants with vaccination and non-pharmaceutical interventions.
    Saha S; Saha AK
    Heliyon; 2023 Jul; 9(7):e17900. PubMed ID: 37539217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the dynamics of acute and chronic hepatitis B with optimal control.
    Khan T; Rihan FA; Ahmad H
    Sci Rep; 2023 Sep; 13(1):14980. PubMed ID: 37696844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal control strategies on HIV/AIDS and pneumonia co-infection with mathematical modelling approach.
    Teklu SW; Terefe BB; Mamo DK; Abebaw YF
    J Biol Dyn; 2024 Dec; 18(1):2288873. PubMed ID: 38140717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non Pharmaceutical Interventions for Optimal Control of COVID-19.
    Zamir M; Shah Z; Nadeem F; Memood A; Alrabaiah H; Kumam P
    Comput Methods Programs Biomed; 2020 Nov; 196():105642. PubMed ID: 32688137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling SARS-CoV-2 and HBV co-dynamics with optimal control.
    Omame A; Abbas M
    Physica A; 2023 Apr; 615():128607. PubMed ID: 36908694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of optimal control strategies on the fungal Tinea capitis infection fractional order model with cost-effective analysis.
    Teklu SW; Meshesha AA; Ullah S
    Sci Rep; 2024 Jan; 14(1):1508. PubMed ID: 38233520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.